Letter of response regarding adrenal SABR to the article published in the March 2024 journal publication: Prospective longitudinal assessment of quality of life after stereotactic ablative radiotherapy for oligometastases: Analysis of the population-based SABR-5 phase II trial by Cruz-Lim et al.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Affiliation
UHBPublication date
2024-04-20Subject
Oncology. Pathology.
Metadata
Show full item recordAbstract
No abstract available.Citation
Irwin A, Clarke H, Ghafoor Q, Watkins S. Letter of Response Regarding Adrenal SABR to the Article Published in the March 2024 Journal Publication: Prospective Longitudinal Assessment of Quality of Life after Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-based SABR-5 Phase II Trial by Cruz-Lim et al. Clin Oncol (R Coll Radiol). 2024 Jul;36(7):e239. doi: 10.1016/j.clon.2024.04.005. Epub 2024 Apr 20.Type
OtherAdditional Links
https://www.sciencedirect.com/science/journal/09366555PMID
38749807Journal
Clinical OncologyPublisher
W.B. Saundersae974a485f413a2113503eed53cd6c53
10.1016/j.clon.2024.04.005